Skip to main content
Equibles

UBS Group AG

Position in TECH — BIO-TECHNE Corp

CIK 1610520 ZURICH, V8
Back to TECH Full portfolio

Position in TECH

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$175,113,583
+$15,493,619 QoQ
Shares Held
2,478,607
-18.8% QoQ
Ownership
1.58%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#17
of 593 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in TECH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. TECH ranks #13 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in TECH

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $175,113,583 2,478,607
2026-03-31 $159,619,964 3,054,343
2025-12-31 $130,808,905 2,224,263
2025-09-30 $83,969,922 1,509,436
2025-06-30 $51,058,257 992,386
2025-03-31 $109,888,446 1,874,270
2024-12-31 $52,423,789 727,805
2024-09-30 $22,088,332 276,346
2024-06-30 $17,630,411 246,063
2024-03-31 $14,881,852 211,420
2023-12-31 $11,029,943 142,949
2023-09-30 $1,926,448 28,301
2023-06-30 $2,793,460 34,221
2023-03-31 $2,094,827 28,236
2022-12-31 $2,261,877 27,291
2022-09-30 $1,872,128 6,592
2022-06-30 $2,685,765 7,748
2022-03-31 $6,457,057 14,911
2021-12-31 $14,683,659 28,383
2021-09-30 $13,200,170 27,241
2021-06-30 $9,976,859 22,158
2021-03-31 $8,734,737 22,870
2020-12-31 $7,050,561 22,203
2020-09-30 $4,991,511 20,149
2020-06-30 $869,581 3,293
2020-03-31 $981,661 5,177